These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 30975595)

  • 21. A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.
    Ansari B; Tote KM; Rosenberg ES; Martin EG
    Public Health Rep; 2020; 135(1_suppl):100S-127S. PubMed ID: 32735190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
    Karamouzian M; Kuo M; Crabtree A; Buxton JA
    Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.
    Hawk KF; Vaca FE; D'Onofrio G
    Yale J Biol Med; 2015 Sep; 88(3):235-45. PubMed ID: 26339206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing the Fentanyl Threat to Public Health.
    Frank RG; Pollack HA
    N Engl J Med; 2017 Feb; 376(7):605-607. PubMed ID: 28199808
    [No Abstract]   [Full Text] [Related]  

  • 25. Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?
    Barry CL
    Psychiatr Serv; 2018 Jan; 69(1):100-103. PubMed ID: 28967324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tackling the overdose crisis: The role of safe supply.
    Ivsins A; Boyd J; Beletsky L; McNeil R
    Int J Drug Policy; 2020 Jun; 80():102769. PubMed ID: 32446183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
    Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What would it really take to solve the overdose epidemic in the United States?
    Rivera BD; Friedman SR
    Int J Drug Policy; 2024 Jun; 128():104435. PubMed ID: 38729061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital Interventions to Save Lives From the Opioid Crisis Prior and During the SARS COVID-19 Pandemic: A Scoping Review of Australian and Canadian Experiences.
    Donnell A; Unnithan C; Tyndall J; Hanna F
    Front Public Health; 2022; 10():900733. PubMed ID: 35903371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
    Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
    J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harm Reduction Strategies for the Opiod Crisis.
    Castillo T
    N C Med J; 2018; 79(3):192-194. PubMed ID: 29735629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis.
    Argento E; Tupper KW; Socias ME
    Int J Drug Policy; 2019 Apr; 66():80-81. PubMed ID: 30743091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction.
    Hill LG; Evoy KE; Reveles KR
    J Am Pharm Assoc (2003); 2019; 59(6):779-782. PubMed ID: 31402146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 'fentanyl epidemic' in Canada - Some cautionary observations focusing on opioid-related mortality.
    Fischer B; Vojtila L; Rehm J
    Prev Med; 2018 Feb; 107():109-113. PubMed ID: 29126920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Research as a Key Component in Mitigating the Opioid Overdose Crisis.
    Baumann MH; Kopajtic TA; Madras BK
    Trends Pharmacol Sci; 2018 Dec; 39(12):995-998. PubMed ID: 30454770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for Reducing Opioid-Overdose Deaths - Lessons from Canada.
    Wood E
    N Engl J Med; 2018 Apr; 378(17):1565-1567. PubMed ID: 29694813
    [No Abstract]   [Full Text] [Related]  

  • 39. The Opioid Epidemic: Task-Shifting in Health Care and the Case for Access to Harm Reduction for People Who Use Drugs.
    Jozaghi E
    Int J Health Serv; 2022 Apr; 52(2):261-268. PubMed ID: 32268811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Could Change the Way We Respond to the Opioid Crisis-for the Better.
    Bao Y; Williams AR; Schackman BR
    Psychiatr Serv; 2020 Dec; 71(12):1214-1215. PubMed ID: 32781928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.